Pharma, Biotech and Generics Industry News | The Pharmaletter
6 天之前 · The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results …
Pharmaceutical Industry News | The Pharmaletter
2024年11月12日 · The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research …
Pharma and Biotech News | The Pharmaletter
6 天之前 · 20 November 2024 Sweden-based Xbrane Biopharma and Intas Pharmaceuticals have announced an exclusive global licensing and co-development agreement for the former …
Pharmaceutical Generics Industry News | The Pharmaletter
2024年9月9日 · Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets.
FDA drug regulation and approval news | The Pharmaletter
2024年11月13日 · Intercept Pharmaceuticals, now wholly owned subsidiary of Italy’s Alfasigma, today revealed that the US Food and Drug Administration (FDA) has issued a Complete …
The week in pharma: action, reaction and insight – …
1 天前 · Research news last week included US biotech Fate releasing early data for its FT819 in the treatment of systemic lupus erythematosus (SLE), which sent the firm’s shares leaping as much as 70%. Also, Netherlands-based …
Pharma and Biotech News in Brief | The Pharmaletter
Sweden-based BioArctic saw its fall 7.5% to 139.90 kronor on Friday, after its announced that its partner, Japan’s Eisa, has updated its revenue outlook for the Alzheimer’s treatment Leqembi …
Pharma and Biotech Regulatory News | The Pharmaletter
5 天之前 · Japanese drugmaker Chugai, which is majority owned by Roche, On Friday revealed that Zenyaku Kogyo has obtained regulatory approval from the Ministry of Health, Labor and …
Pharma and Biotech Diabetes News | The Pharmaletter
2024年11月12日 · US pharma major AbbVie last week proposed $1.4 billion acquisition of US CNS drug developer Aliada Therapeutics. Last week saw a bunch of third quarter 2024 …
Biotech Industry News | The Pharmaletter
2024年11月11日 · Merck & Co has entered into an exclusive global license to develop, manufacture and commercialize LM-299 from China-based clinical-stage biotech LaNova …